Brief: Calliditas Therapeutics Reconfirms Net Sales Guidance For 2023
07/11/2023 06:10
Nov 7 (Reuters) - Calliditas Therapeutics AB CALTX.ST :
* WE RECONFIRM OUR GUIDANCE FOR 2023 OF USD 100 - 120M OF
NET
SALES FROM TARPEYO
Source text for Eikon: ID:nWkrz0w2Q
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations